Summary

The immediate task for semiconductor supply chains is not to remove every PFAS-containing material, but to identify where PFAS performs a critical function, what evidence supports that use, and how a replacement would be qualified without creating a new process risk.

What Changed in the PFAS Review

The consultation on the European Chemicals Agency’s Committee for Socio-Economic Analysis, or SEAC, draft opinion ran from March 26 to May 25, 2026. SEAC is now reviewing the submitted technical and socio-economic evidence and is expected to adopt its final opinion by the end of 2026.

The restriction remains a proposal under REACH. The European Commission has not adopted a final legal text, no entry-into-force date has been established, and no current general application deadline applies to semiconductor photoresists, fluorinated surfactants, or equipment seals.

According to the ECHA update on the PFAS committee opinions, the Risk Assessment Committee adopted its final opinion on March 2, 2026, while SEAC agreed its draft opinion on March 10, 2026. These committee opinions inform the legislative process; they are not the final restriction.

Regulatory Dates That Must Not Be Confused

The SEAC draft opinion considers the proposed semiconductor-manufacturing derogation likely justified and recommends retaining a period of 13.5 years after a future entry-into-force date. This remains a draft committee position. It is not an active transition period, and its wording, duration, or conditions may change before a final restriction is adopted.

The Real Question Is Not Simply Whether a Material Contains PFAS

A PFAS declaration answers a composition question. It does not establish why the substance is used, whether it is critical to the process, how releases are managed, or whether a technically qualified alternative exists.

A fluorinated surfactant used at a low concentration in a photoresist is not equivalent to a fluoroelastomer used in a vacuum-system O-ring. Both may fall within a broad PFAS definition, yet their functions, release routes, replacement risks, and regulatory use categories differ.

Photolithography materials, etching chemicals, chamber-cleaning materials, wafer-processing formulations, and some semiconductor equipment applications may be assessed within the electronics and semiconductors sector.

General gaskets, O-rings, pipe linings, pumps, and machinery parts may fall under separate sealing or machinery categories, even when they are installed inside a semiconductor facility.

Buyers should avoid using one facility-wide justification such as “required for semiconductor manufacturing.” Evidence should identify the exact product, component, process step, and technical function.

Evidence for Photoresists and Lithography Additives

PFAS may be present in photoacid generators, fluorinated surfactants, anti-reflective coatings, immersion barriers, topcoats, underlayers, image-sensor materials, and developer rinse formulations.

The evidence package should connect the PFAS component to a defined formulation role and a measurable process result.

These fields are a practical preparation framework, not a binding EU documentation checklist.

A replacement assessment should compare alternatives against the same technical function and representative production conditions. This functional-equivalence principle is also examined in EU 2026 SSbD Revision: Performance and Lifecycle Evidence for Specialty Chemical Substitution, which explains why an apparently safer substitute cannot be evaluated only by chemical name, dosage, or an isolated laboratory result.

Photoacid Generators

A photoacid generator, or PAG, must do more than release acid after exposure. Its suitability can depend on acid strength, diffusion behaviour, solubility, compatibility with the polymer matrix, thermal stability, and wavelength-dependent absorption.

A candidate that works in a 248 nm formulation may not meet the requirements of a 193 nm or immersion-lithography process. A change in PAG chemistry can affect photospeed, feature profile, line-width roughness, post-exposure bake behaviour, and interaction with other resist components.

Evidence should remain formulation-specific. A successful replacement in one resist family does not prove suitability across every qualified grade.

Fluorinated Surfactants

Fluorinated surfactants may be used at low concentrations while influencing coating uniformity, wetting, resist removal, pattern collapse, line-edge roughness, and defect performance.

The SIA case study on PFAS-containing semiconductor surfactants describes qualification as a multi-stage process extending from chemical development through formulation assessment and device-manufacturer validation. It also explains why substitution normally has to be evaluated material by material rather than treated as a universal drop-in replacement.

A buyer should ask what failed when a non-fluorinated candidate was rejected. “Poor performance” does not provide enough evidence.

The failure may involve:

• Surface tension or contact angle;
• Coat uniformity or film thickness;
• Haze, agglomeration, or filtration behaviour;
• Pattern collapse or incomplete resist removal;
• Residue or defect counts;
• Shelf life and formulation stability;
• Etch compatibility or downstream yield.

Surface-tension data may support the explanation. It cannot establish production suitability on its own.

Another common mistake is assuming that every grade within a formulation family has the same PFAS profile. A fluorinated additive may be critical in an advanced resist while unnecessary in a less demanding coating. The evidence should be organised by grade, formulation, and process rather than by trade name alone.

Equipment Seals Require a Separate Technical Case

Fluoroelastomer and perfluoroelastomer seals may be used in valves, pumps, vacuum chambers, chemical-delivery systems, plasma tools, and wet-process equipment. Their presence inside a semiconductor facility does not automatically place them within the semiconductor-manufacturing derogation.

The technical case should begin with actual operating conditions:

• Process chemicals and concentration ranges;
• Exposure duration and temperature;
• Vacuum, pressure, and pressure cycling;
• Plasma species and erosion conditions;
• Compression-set and permeation requirements;
• Particle, extractable, and outgassing limits;
• Expected maintenance interval;
• Qualified spare-part availability.

A compatibility chart can support preliminary screening. It does not qualify a replacement seal for a specific tool.

An alternative elastomer may resist the process liquid but fail through swelling, compression loss, plasma degradation, particle generation, permeation, or a shorter service life. These failures can affect contamination control and equipment availability without appearing in a basic immersion test.

Newly designed and legacy equipment also need different assessments. A new tool may allow changes to seal geometry or maintenance design. An installed tool may depend on validated spare parts, fixed service intervals, and narrow contamination limits.

What Existing Documents Can and Cannot Prove

PFAS declarations, safety data sheets, certificates of analysis, and change notifications answer different questions. Collecting all four does not automatically create a complete evidence package.

A statement such as “PFAS-free” has limited value unless it identifies the definition used. It should also clarify whether the declaration covers intentionally added substances, residuals, impurities, fluoropolymers, packaging, and contact components.

An SDS should not be treated as a complete composition certificate. Low-concentration additives, proprietary ingredients, polymers, and non-hazardous components may not appear as individually disclosed substances.

A COA confirms whether a batch meets agreed release limits. It rarely explains why PFAS is present or whether a reformulated material is technically equivalent.

Change control may become commercially important before a final restriction applies. Procurement terms should cover advance notice, affected raw materials, sample availability, comparison data, transition lots, traceability, and the remaining supply of the qualified grade.

Sample Approval Is Not Production Qualification

A PFAS-free or lower-PFAS candidate may pass laboratory screening and still fail during tool trials, extended qualification, or routine batch supply.

For a photoresist, sample testing may confirm viscosity, coating behaviour, sensitivity, and initial pattern quality. A production trial must examine the actual wafer layer, tool settings, defect inspection, etch integration, and yield impact.

For a seal, coupon immersion can identify obvious incompatibility. It cannot replace installation testing under vacuum, compression, thermal cycling, plasma exposure, and the intended maintenance period.

Batch purchasing creates another risk. The commercial material must remain aligned with the qualified sample in raw-material source, filtration, concentration range, manufacturing route, packaging, and storage condition.

A reformulated product may remain within a broad COA specification while behaving differently in the customer’s process. The same sample-to-commercial-supply risk is examined in How to Qualify Electronic-Grade Hydrogen Peroxide for Bulk Procurement, where the approved material must remain traceable across specification, analytical method, packaging, and routine production lots.

The Compliance Bottleneck Is Traceability, Not a PFAS-Free Certificate

Current industry discussion often asks whether semiconductor manufacturing can become completely PFAS-free. That question is too broad to guide procurement or technical validation.

Some PFAS uses sit inside sensitive lithography steps where a change can affect pattern geometry, defectivity, integration, and reliability. Other uses may be found in supporting formulations or less critical equipment components where alternatives can be assessed with lower qualification risk.

Treating every PFAS use as equally essential weakens the justification for genuinely critical uses. Treating every use as immediately replaceable shifts qualification risk downstream without identifying where failure is most likely.

The impact most likely to be overstated is an immediate interruption of European semiconductor production. The restriction has not been adopted, no application date exists, and the SEAC draft supports a targeted semiconductor-manufacturing derogation.

The more easily overlooked problem is the traceability gap between a finished product and the upstream PFAS function.

A wafer manufacturer may know that a resist is qualified without knowing the identity or concentration range of the fluorinated surfactant. A distributor may hold an SDS and COA without access to the proprietary formulation. An equipment team may know that a seal survives two maintenance cycles without having a controlled comparison against alternative materials.

One standard questionnaire will not close these gaps because each supply-chain participant controls a different part of the evidence:

• The chemical producer holds substance and synthesis information;
• The formulator understands the component’s role;
• The distributor controls commercial traceability and change communication;
• The device manufacturer holds process, defect, and yield data;
• The equipment supplier controls component specifications and tool qualification.

A more useful internal record is a ranked use map:

• High process criticality with weak alternative evidence;
• High criticality with active replacement development;
• Lower criticality with credible alternatives;
• Unknown composition requiring clarification;
• Legacy spare parts requiring continuity planning.

Buyers can reasonably expect more definition-specific PFAS declarations, process-use questionnaires, qualification requests, and stricter change-notification terms before a final restriction applies. These are preparation measures, not evidence that a legal prohibition has already taken effect.

Short-Term and Mid-Term Implications

The first two changes are consistent with the current evidence-review stage. Later outcomes will depend on SEAC’s final opinion and the European Commission’s legal proposal.

What Is Not Yet Required—and What May Still Change

The present committee stage does not automatically prohibit the sale or use of PFAS-containing photoresists, surfactants, or equipment seals.

Existing material qualifications do not expire because the SEAC consultation has closed. A product does not become non-compliant solely because it contains a substance within the proposed PFAS definition.

Existing substance-specific EU restrictions continue to apply independently. The pending broader proposal does not suspend obligations already established for individual PFAS.

SEAC may revise its draft conclusions after reviewing the consultation evidence. The European Commission may later change:

• The substance and use scope;
• Concentration thresholds;
• Derogation wording and duration;
• Reporting and management-plan requirements;
• Emission-control conditions;
• Treatment of imported mixtures and articles;
• Spare-parts provisions;
• Application and transition dates.

The practical task is not to predict the final wording. It is to connect every critical material to a defined function, measurable performance requirement, realistic alternative assessment, controlled validation stage, and traceable commercial supply.

Buyers assessing electronic chemicals and advanced specialty materials can submit their target specifications, PFAS documentation requirements, and current qualification stage to ChemicalCell for a focused sourcing discussion.